![Nathalie Riebel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Nathalie Riebel, formerly a Director of Clinical Operations at ImClone LLC, Director of Global Quality & Inspection at Eli Lilly & Co., Director of Clinical Operations at ICON plc, Director of Clinical Operations at GSK Plc, and currently serving as the Senior Vice President of Clinical Operations at PDS Biotechnology Corp.
Former positions of Nathalie Riebel
| Companies | Position | End |
|---|---|---|
| PDS BIOTECHNOLOGY CORPORATION | Chief Tech/Sci/R&D Officer | 01/12/2023 |
| ICON PUBLIC LIMITED COMPANY | Chief Tech/Sci/R&D Officer | 01/03/2011 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Chief Tech/Sci/R&D Officer | - |
| GSK PLC | Chief Tech/Sci/R&D Officer | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
20
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
ICON plc
 ICON plc Miscellaneous Commercial ServicesCommercial Services Provides clinical research and development services | Commercial Services |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
PDS Biotechnology Corp.
 PDS Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Develops clinical-stage immunotherapies to treat various early-stage and late-stage cancers which includes head & neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer and related cancers | Health Technology |
- Stock Market
- Insiders
- Nathalie Riebel
